Author Correction: The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study

Clicks: 38
ID: 283399
2025
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Abstract is not available for this article.
Login to Search Abstract
Reference Key
Özyurt2025author Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors N. Özyurt; Ali Alkan; B. Gülbağcı; Mustafa Seyyar; Esra Aşık; Mustafa Şahbazlar; Mehmet Türker; Oğuzcan Kınıkoğlu; Tahir Yerlikaya; Gülhan Dinç; Ali Aytaç; Z. Kalkan; Senar Ebinç; Ilkay Gültürk; Merve Keskinkilic; Zehra Sucuoglu Isleyen; D. Çağlayan; Alper Türkel; Esra Aydın; T. Şakalar; Serhat Sekmek; N. Yıldırım; Sinem Koçak; K. Okutur; A. Özveren; B. Dursun; Sait Kitaplı; O. Eren; I. Beypınar; I. Hacibekiroglu; D. Çabuk; Elanur Karaman; Ömer Acar; S. Paydaş; M. Eryılmaz; B. Demi̇r; Z. Oruç; Mesut Yılmaz; F. Biricik; D. Salim; Özgür Tanrıverdi; M. Doğan
Journal Scientific reports
Year 2025
DOI
10.1038/s41598-024-80587-9
URL
https://www.semanticscholar.org/paper/9dd7a0dfd8e8d731d171a20f17d17c98e5e301bd
Keywords
oncology impact turkish status her2 author breast group negative prognostic triple study early cancer: correction: (tog)

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.